Identification of serum sirtuins as novel noninvasive protein markers for frailty R Kumar, N Mohan, AD Upadhyay, AP Singh, V Sahu, S Dwivedi, AB Dey, ... Aging cell 13 (6), 975-980, 2014 | 108 | 2014 |
Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway S Shekhar, Y Yadav, AP Singh, R Pradhan, GR Desai, AB Dey, S Dey Experimental gerontology 110, 277-283, 2018 | 40 | 2018 |
Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease R Kumar, L Nigam, AP Singh, K Singh, N Subbarao, S Dey European journal of medicinal chemistry 127, 909-916, 2017 | 40 | 2017 |
Serum mortalin correlated with α-synuclein as serum markers in Parkinson’s disease: a pilot study AP Singh, T Bajaj, D Gupta, SB Singh, A Chakrawarty, V Goyal, AB Dey, ... Neuromolecular medicine 20, 83-89, 2018 | 24 | 2018 |
Elevated Serum SIRT 2 May Differentiate Parkinson’s Disease From Atypical Parkinsonian Syndromes AP Singh, G Ramana, T Bajaj, V Singh, S Dwivedi, M Behari, AB Dey, ... Frontiers in molecular neuroscience 12, 129, 2019 | 18 | 2019 |
Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson’s disease AP Singh, L Nigam, Y Yadav, S Shekhar, N Subbarao, S Dey Molecular Diversity 25, 2261-2270, 2021 | 13 | 2021 |
NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma A Gupta, R Kumar, V Sahu, V Agnihotri, AP Singh, S Bhasker, S Dey Biochemical and biophysical research communications 467 (2), 248-253, 2015 | 10 | 2015 |
Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson's disease A Singh, T Bajaj, A Dey, S Dey MOVEMENT DISORDERS 34, 2019 | | 2019 |
Molecular Marker and Therapeutic Regimen for Neurodegenerative Diseases S Dey, N Rai, S Shekhar, AP Singh, V Agnihotri Models, Molecules and Mechanisms in Biogerontology: Physiological …, 2019 | | 2019 |
Level of serum Mortalin in Parkinson's disease correlating with alpha-Synuclein: Assessment of protein marker for early detection S Dey, A Singh, T Bajaj, AB Dey MOVEMENT DISORDERS 33, S121-S121, 2018 | | 2018 |
Assessment of Serum Mortalin in Parkinson's Disease Correlating with Alpha-Synuclein A Singh, T Bajaj, V Goyal, S Dey MOVEMENT DISORDERS 33, S106-S106, 2018 | | 2018 |
[P1–125]: BLOOD MARKER FOR EARLY DETECTION OF ALZHEIMER'S DISEASE AP Singh, R Kumar, AB Dey, S Dey Alzheimer's & Dementia 13 (7S_Part_5), P289-P290, 2017 | | 2017 |
[P3–244]: SESTRIN LEVELS IN PATIENTS DIAGNOSED WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER's DISEASE: A POTENTIAL MARKER N Rai, AP Singh, S Shekhar, Y Yadav, AB Dey, S Dey Alzheimer's & Dementia 13 (7S_Part_21), P1033-P1034, 2017 | | 2017 |
REMOVED: Promising serum protein marker for early detection of Alzheimer's disease R Kumar, A Gupta, V Sahu, AP Singh, S Kumar, K Singh, AB Dey, S Dey International Journal of Developmental Neuroscience 47, 4, 2015 | | 2015 |